/Investor DB

Advantech Capital

Private equity

Camana Bay · Growth · 3 people tracked

Find your way into Advantech Capital

Sign up to see every warm intro you have to Advantech Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Advantech Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Advantech Capital is a private equity fund that invests in technology, media, telecommunications, pharmaceuticals, and healthcare companies in China.

Source: firm website, verified Oct 13, 2026.

Stage
Growth
HQ
Camana Bay, CN
Instruments
Equity
Founded
2016
AUM
$560M
Tracked investments
3
Unicorns
1
IPOs
1

Team · 3 people

from public directories
Kok Wai Wong· Director

What they invest in

from 2 of 3 portfolio companies

Biotech ×2Medical Devices ×2Digital Health ×1Healthtech ×1

HQs:China×1United States×1

Investments · 3 tracked

founders shown can be your intro path
Zai Labzailaboratory.comin𝕏NASDAQ: ZLAB

Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States.

BiotechHealthtechMedical Devices

Samantha (Ying) Du(Founder, Chief Executive Officer, Chairperson of the Board of Directors)inYajing Chen(Chief Financial Officer)inRafael G. Amado(President, Head of Global Research and Development)inF. Ty Edmondson(Chief Legal Officer)inJosh Smiley(President and Chief Operating Officer)Samantha Du(Founder)

Co-investorsQiming Venture PartnersVivo CapitalYuanBio Venture CapitalHongShan Capital GroupKleiner PerkinsSequoia Capital

Spot Biosystemsspotbiosystems.comin

Spot Biosystems is a clinical-stage biopharmaceutical company developing non-viral gene therapies using extracellular vesicles as a delivery method.

BiotechDigital HealthMedical Devices

Co-investorsSaltagen VenturesStartXIDG CapitalLDV Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Petuum Holdings

Exits · 1

1 IPOs

Zai LabNASDAQ: ZLAB

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Zai Lab12.3%$20.00Sep 2018$143.3M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

What stage does Advantech Capital invest at?
Advantech Capital invests at the Growth stage.
What sectors does Advantech Capital focus on?
Advantech Capital focuses on Advanced Manufacturing, Biotech, Consumer, Data & Infrastructure, Enterprise Software, Healthtech, Media & Entertainment, Medical Devices, SaaS.
Where is Advantech Capital located?
Advantech Capital is headquartered in Camana Bay, CN.

Similar investors

Featured in lists